Tag Archives: triple-negative breast cancer

Triple-negative breast cancer exosomes reshape T cell activity, gene expression, and immune receptor populations, revealing how extracellular vesicles may influence anti-tumor immunity...

Engineered extracellular vesicles carrying a 15-miRNA combination suppressed aggressive cancer behavior, supporting their potential as delivery...

Engineered extracellular vesicles increased cancer cell detection sensitivity, enabling highly selective liquid biopsy approaches and supporting future advances in targeted drug delivery...

Extracellular vesicles can be reprogrammed to stimulate anticancer immunity, offering a new strategy to improve immunotherapy and reduce...

Extracellular vesicles isolated from blood may help predict treatment response and early relapse in triple-negative breast cancer using aptamer-based protein profiling...

Extracellular vesicles and exosomes engineered as targeted delivery vehicles may support treatment of heart disease while improving cancer therapy...

Engineered extracellular vesicles and exosomes improve delivery of PROTAC drugs to aggressive breast tumors, enhancing stability, tumor penetration, and antitumor effects in preclinical...

Extracellular vesicles and exosomes act as the body’s molecular messengers, influencing immune responses, cancer metastasis, and inflammation...

Adipocyte-derived exosomes carrying microRNAs can worsen triple-negative breast cancer, especially in patients with insulin resistance or diabetes, promoting aggressive tumor growth and brain metastasis, highlighting a link between metabolism and...

INOVIQ announced that it has successfully completed stage 1 of its development program for an exosome therapeutic for breast cancer. In this in vitro proof-of-concept (POC) study, immortalised...